Jaws Acquisition Corp. (JWS): Price and Financial Metrics


Jaws Acquisition Corp. (JWS): $14.75

-0.11 (-0.74%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

JWS Stock Price Chart Interactive Chart >

Price chart for JWS

JWS Price/Volume Stats

Current price $14.75 52-week high $17.43
Prev. close $14.86 52-week low $9.95
Day low $14.57 Volume 1,132,300
Day high $15.56 Avg. volume 904,340
50-day MA $13.37 Dividend yield N/A
200-day MA $12.53 Market Cap 1.27B

Jaws Acquisition Corp. (JWS) Company Bio


Jaws Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2019 and is based in Miami Beach, Florida.


JWS Latest News Stream


Event/Time News Detail
Loading, please wait...

JWS Latest Social Stream


Loading social stream, please wait...

View Full JWS Social Stream

Latest JWS News From Around the Web

Below are the latest news stories about Jaws Acquisition Corp that investors may wish to consider to help them evaluate JWS as an investment opportunity.

Cano Health Closes Business Combination with Jaws Acquisition Corp. and Will Begin Trading on the New York Stock Exchange

Cano Health, Inc. ("Cano Health," the "Company," "we," "our" or "us"), a leading value-based primary care provider for seniors and underserved communities, today announced it has completed its business combination with Jaws Acquisition Corp. ("Jaws") (NYSE: JWS). The business combination, which was approved by Jaws' stockholders at its special meeting held on June 2, 2021, will enable Cano Health to achieve its vision of becoming America's leader in primary care and accelerate the Company's grow

Yahoo | June 3, 2021

Jaws Acquisition Corp. Announces Extraordinary General Meeting Teleconference Details

Jaws Acquisition Corp. ("Jaws") (NYSE: JWS), today announced that, due to the public health and safety concerns related to the coronavirus (COVID-19) pandemic and recommendations and orders from federal and New York authorities, it is strongly encouraging that shareholders attend the extraordinary general meeting of its shareholders, which will be held on June 2, 2021 at 9:00 a.m., New York City Time (the "General Meeting"), by teleconference rather than in person. The purpose of the General Meeting is to vote on certain proposals relating to the previously announced merger between Jaws and Cano Health, LLC ("Cano Health" or the "Company"), the related Business Combination Agreement, dated as of November 11, 2020 (as amended or supplemented from time to time, the "Business Combination A...

Yahoo | May 24, 2021

Jaws Acquisition Corp. Announces Effectiveness of Registration Statement and Sets Special Meeting Date for Proposed Business Combination with Cano Health

Jaws Acquisition Corp. (NYSE: JWS), a special purpose acquisition company ("Jaws"), announced today the effectiveness of its Registration Statement, in connection with its previously announced merger with Cano Health, LLC ("Cano Health"), on Form S-4, with the United States Securities and Exchange Commission (the "SEC"). Jaws also announced a special meeting of its shareholders (the "Special Meeting") to approve the proposed merger agreement with Cano Health for June 2, 2021 at 9:00 a.m., Eastern Time, unless postponed or adjourned to a later date or time. Jaws will distribute the definitive proxy statement and proxy card to its stockholders of record as of March 24, 2021, the record date for the Special Meeting.

Yahoo | May 10, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of VIE, FFG, JWS, and RNET Mergers

WILMINGTON, Del., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating: Viela Bio, Inc. (NASDAQ GS: VIE) regarding possible breaches of fiduciary duties and other violations of law related to Viela Bio’s agreement to be acquired by Horizon Therapeutics plc. Under the terms of the agreement, Viela Bio’s shareholders will receive $53.00 in cash per share. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-viela-bio-inc. FBL Financial Group, Inc. (NYSE: FFG) regarding possible breaches of fiduciary duties and other violations of law related to FBL Financial’s agreement to be acquired by Farm Bureau Property & Casualty Insurance Company. Under the terms of the agreement, FBL Financial’s shareholders will receive ...

Yahoo | February 19, 2021

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of ANCN, JWS, GXGX, and ALSK Mergers

WILMINGTON, Del., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating: Anchiano Therapeutics Ltd. (NASDAQ GS: ANCN) regarding possible breaches of fiduciary duties and other violations of law related to Anchiano Therapeutics’ agreement to merge with Chemomab Ltd. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-anchiano-therapeutics-ltd. Jaws Acquisition Corp. (NYSE: JWS) regarding possible breaches of fiduciary duties and other violations of law related to Jaws Acquisition’s agreement to merge with Cano Health, LLC. To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-jaws-acquisition-corp. GX Acquisition Corp. (NASDAQ GS: GXGX) regarding possible breaches of fiduc...

Yahoo | January 26, 2021

Read More 'JWS' Stories Here

JWS Price Returns

1-mo 12.68%
3-mo 6.96%
6-mo 7.27%
1-year N/A
3-year N/A
5-year N/A
YTD 9.99%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7871 seconds.